Send Enquiry

MEDANOR
Tablets
Packaging and packing Type
Blister | 10x15
MRP :
₹194
PTR :
₹147.81
PTS :
₹133.03
Prescription medicine Read More
Composition
Send Enquiry
India’s Trusted Pharma Brand
100%
Genuine Products
Secure
Payments
24 x 7
Customer Support
About the product
By Vibcare Pharma · Updated 9 October 2026 · Based on product labels and standard drug references
Glimcod M3 is a tablet form of the combination Glimepiride 3 mg and Metformin 500 mg. The pair falls under the oral anti-diabetic class, a sulfonylurea together with a biguanide. Each pack is made as 10x15 (Blister) and the brand comes from Vibcare Pharma's Medanor division.
In this tablet, glimepiride works on the beta cells of the pancreas and helps them release insulin, which carries sugar out of the blood. Metformin cuts down the sugar the liver puts out and improves how the body responds to insulin. Since each ingredient works by a different route, blood sugar is supported from two directions.
Doctors prescribe these tablets along with diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Severe hypoglycemia is a risk, and metformin carries a risk of lactic acidosis.
Use only on a doctor's prescription, at the dose and for the duration advised.
Common
Get medical help at once if you notice
Do not use
Ask a doctor first
Glimcod M3 tablets carry Glimepiride 3 mg with Metformin 500 mg to improve glycemic control in type 2 diabetes. Main uses: as an add-on to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus; helps lower raised blood sugar through two different actions: insulin release and reduced liver sugar output; used in type 2 diabetes when diet and exercise alone do not keep blood sugar in range.
Common side effects of Glimcod M3 Tablet include low blood sugar (hypoglycemia); headache; dizziness; nausea; weakness or tiredness (asthenia); diarrhoea and stomach discomfort. Get medical help at once if you notice severe hypoglycemia; lactic acidosis, a serious condition linked to metformin; severe allergic reactions such as anaphylaxis, angioedema or Stevens-Johnson syndrome.
Each Glimcod M3 tablet contains Glimepiride 3 mg + Metformin 500 mg. The right dose and how long to take it depend on the condition, age and other medicines, so use Glimcod M3 Tablet only as your doctor advises.
The MRP of Glimcod M3 Tablet is ₹194 for a pack of 10x15 (Blister). For chemists and distributors, the PTR is ₹147.81 and the PTS is ₹133.03.
Each Glimcod M3 tablet contains Glimepiride 3 mg + Metformin 500 mg. It comes in a pack of 10x15 (Blister).
In this tablet, glimepiride works on the beta cells of the pancreas and helps them release insulin, which carries sugar out of the blood. Metformin cuts down the sugar the liver puts out and improves how the body responds to insulin. Since each ingredient works by a different route, blood sugar is supported from two directions.
Must not be used for type 1 diabetes mellitus or diabetic ketoacidosis. Must not be used in severe kidney impairment or in metabolic acidosis. Must not be used by anyone allergic to glimepiride, metformin, sulfonamide derivatives or any ingredient of the tablet. Check with a doctor first if you are elderly, or have reduced kidney or liver function, G6PD deficiency or heavy alcohol intake. Check with a doctor first if you are pregnant or breastfeeding.
Glimcod M3 Tablet is a brand of Vibcare Pharma, sold through its Medanor division. It is available for PCD pharma franchise and distribution in India; use the Send Enquiry or WhatsApp button on this page to ask about availability and terms.
Similar Products
Send Enquiry
Request a callback to get more information about becoming a PCD Franchise Owner